论文信息 - P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab - 字舞流文

P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab

V. Velcheti | J. Mazières | J. Goldschmidt | R. Natale | A. Spira | M. Gandhi | M. Kosty | Wei Yu | Anthony Lee | G. Shankar | J. Rothenstein | C. Thomas | M. Kozloff | S. P. Aix | W. Lin